Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu–NYM032 for theranostic use in prostate cancer.

Purpose: A novel theranostic radiopharmaceutical targeting prostate-specific membrane antigen (PSMA), [68Ga]Ga/[177Lu]Lu–NYM032, was developed and its diagnostic and therapeutic potential in the treatment of prostate cancer (PCa) was preliminarily evaluated. Methods: The diagnostic efficacy of the P...

Full description

Bibliographic Details

Published in:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 52; no. 5; pp. 1671 - 1685
Main Authors:	Fu, Haitian, He, Huihui, Wang, Yanjuan, Li, Wenjin, Luo, Yihui, Chen, Liping, Mi, Yuanyuan, Sun, Chengwen, Mao, Yong, Yu, Chunjing
Format:	Journal Article
Published:	Springer Nature Apr2025
Online Access:	View this record in EBSCOhost